Free Trial
TSE:CXF

CI Canadian Convertible Bond ETF Common (CXF) Stock Price, News & Analysis

CI Canadian Convertible Bond ETF Common logo
C$10.02 -0.10 (-0.99%)
As of 02/21/2025 03:25 PM Eastern

About CI Canadian Convertible Bond ETF Common Stock (TSE:CXF)

Key Stats

Today's Range
C$10.02
C$10.12
50-Day Range
C$10.02
C$10.52
52-Week Range
C$9.45
C$10.57
Volume
4,500 shs
Average Volume
4,165 shs
Market Capitalization
C$50.65 million
P/E Ratio
N/A
Dividend Yield
4.79%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs include ONC201 a program for treating tumors which harbor the H3 K27M mutation in recurrent diffuse midline glioma patients; ONC206, an imipridone, Dopamine Receptor D2 (DRD2) antagonist, and caseinolytic protease P (ClpP) agonist that demonstrated enhanced non-competitive DRD2 antagonism relative to ONC201, which is in Phase I clinical trials to treat solid tumors; ONC212, an imipridone agonist of the orphan G protein-coupled receptors (GPCR) tumor suppressor GPR132, as well as ClpP for solid tumors and hematological malignancies, including pancreatic cancer and leukemias; and dociparstat sodium (DSTAT), which inhibits the activities of key proteins implicated in the resistance of acute myeloid leukemia blasts and leukemic stem cells to chemotherapy. The company has license agreements with Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; Cantex Pharmaceuticals, Inc. to develop and commercialize a glycosaminoglycan compound; and SymBio Pharmaceuticals to develop, manufacture, and commercialize BCV for various human indications. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.

Receive CXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CI Canadian Convertible Bond ETF Common and its competitors with MarketBeat's FREE daily newsletter.

CXF Stock News Headlines

Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”
Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?
CI Canadian Convertible Bond ETF Common (CXF.TO)
ETHXF CI GALAXY ETHEREUM ETF
Miller Convertible Bond I
CMNY:CA CI Money Market ETF
See More Headlines

CXF Stock Analysis - Frequently Asked Questions

CI Canadian Convertible Bond ETF Common's stock was trading at C$10.29 at the beginning of the year. Since then, CXF stock has decreased by 2.6% and is now trading at C$10.02.
View the best growth stocks for 2025 here
.

Shares of CXF stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that CI Canadian Convertible Bond ETF Common investors own include Golden Minerals (AUMN), Tesla (TSLA), iA Financial (IAG), Northland Power (NPI), Allied Properties Real Estate Investment Trust (AP.UN), Capital Power (CPX) and Enerplus (ERF).

Industry, Sector and Symbol

Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
CIK
N/A
Web
N/A
Fax
N/A
Employees
90
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$50.65 million
Optionable
Not Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (TSE:CXF) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners